| 11541076 |
Chimeric antigen receptors targeting TIM-1 |
Terrance A. Stadheim, Joana M. MURAD, Jake Reder, Li-Zhen HE, Tibor Keler |
2023-01-03 |
| 11180566 |
Antibodies that bind human CD27 and uses thereof |
Tibor Keler, Lizhen He, Laura A. VITALE, Lawrence J. Thomas |
2021-11-23 |
| 9649357 |
Treatment of chronic nephropathies using soluble complement receptor type I (sCR1) |
Richard J. H. Smith, Yuzhou Zhang |
2017-05-16 |
| 9295713 |
Treatment of chronic nephropathies using soluble complement receptor type I (sCR1) |
Richard J. H. Smith, Yuzhou Zhang |
2016-03-29 |
| 9290946 |
Methods and devices for aligning and coupling a roofing profile to a roof |
William Runyon |
2016-03-22 |
| 9169325 |
Antibodies that bind human CD27 and uses thereof |
Tibor Keler, Lizhen He, Laura A. VITALE, Lawrence J. Thomas |
2015-10-27 |
| 8664176 |
Treatment for age-related macular degeneration and other diseases of the eye |
Lawrence J. Thomas, Hua Gao, Xiaoxi Qiao |
2014-03-04 |
| 6316604 |
Human C3b/C4b receptor (CR1) |
Douglas T. Fearon, Lloyd B. Klickstein, Winnie W. Wong, Gerald R. Carson, Michael F. Concino +2 more |
2001-11-13 |
| 6057131 |
Preparation and use of sialylated glycoforms of soluble complement receptor 1 (CR1) |
Richard A. G. Smith, Chang-Jing Grace Yeh, John Lifter, Anne Mary Freeman, Michael L. Gosselin |
2000-05-02 |
| 5981481 |
Human C3b/C4b receptor (CR1) |
Douglas T. Fearon, Lloyd B. Klickstein, Winnie W. Wong, Gerald R. Carson, Michael F. Concino +2 more |
1999-11-09 |
| 5858969 |
Therapeutic methods employing sialylated glycoforms of soluble complement receptor 1 (SCR 1) |
Richard A. G. Smith, Chang-Jing Grace Yeh, John Lifter, Anne Mary Freeman, Michael L. Gosselin |
1999-01-12 |
| 5856297 |
Human C3b/C4b receptor (CR1) |
Douglas T. Fearon, Lloyd B. Klickstein, Winnie W. Wong, Gerald R. Carson, Michael F. Concino +2 more |
1999-01-05 |
| 5808109 |
Compounds that inhibit complement and/or suppress immune activity |
Robert D. Sindelar, Barton James Bradbury, Teodoro S. Kaufman, Stephen H. Ip, Chew Lee |
1998-09-15 |
| 5656659 |
Compounds which inhibit complement and/or suppress immune activity |
Robert D. Sindelar, Barton James Bradbury, Teodoro S. Kaufman, Stephen H. Ip, Chew Lee |
1997-08-12 |
| 5506247 |
Compounds that inhibit complement and/or suppress immune activity |
Robert D. Sindelar, Barton James Bradbury, Teodoro S. Kaufman, Stephen H. Ip, Chew Lee |
1996-04-09 |
| 5472939 |
Method of treating complement mediated disorders |
Douglas T. Fearon, Lloyd B. Klickstein, Winnie W. Wong, Gerald R. Carson, Michael F. Concino +2 more |
1995-12-05 |
| 5456909 |
Glycoform fractions of recombinant soluble complement receptor 1 (sCR1) having extended half-lives in vivo |
Richard A. G. Smith, Chang-Jing Grace Yeh, John Lifter, Anne Mary Freeman, Michael L. Gosselin |
1995-10-10 |
| 5401767 |
Compounds which inhibit complement and/or suppress immune activity |
Robert D. Sindelar, Barton James Bradbury, Teodoro S. Kaufman, Stephen H. Ip |
1995-03-28 |
| 5366986 |
Compounds which inhibit complement and/or suppress immune activity |
Robert D. Sindelar, Barton James Bradbury, Teodoro S. Kaufman, Stephen H. Ip, Chew Lee |
1994-11-22 |
| 5256642 |
Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof |
Douglas T. Fearon, Lloyd B. Klickstein, Winnie W. Wong, Gerald R. Carson, Michael F. Concino +2 more |
1993-10-26 |
| 5173499 |
Compounds which inhibit complement and/or suppress immune activity |
Robert D. Sindelar, Barton James Bradbury, Teodoro S. Kaufman, Stephen H. Ip |
1992-12-22 |
